Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade C 18.66 2.30% 0.42
MYOV closed up 2.3 percent on Wednesday, January 16, 2019, on 1.3 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MYOV trend table...

Date Alert Name Type % Chg
Jan 16 Crossed Above 50 DMA Bullish 0.00%
Jan 16 MACD Bullish Centerline Cross Bullish 0.00%
Jan 16 Pocket Pivot Bullish Swing Setup 0.00%
Jan 16 Stochastic Reached Overbought Strength 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 16 Upper Bollinger Band Touch Strength 0.00%
Jan 15 50 DMA Resistance Bearish 2.30%
Jan 14 Down 3 Days in a Row Weakness 7.74%
Jan 11 Narrow Range Bar Range Contraction 4.89%
Jan 11 NR7 Range Contraction 4.89%

Older signals for MYOV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Is MYOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 27.45
52 Week Low 12.76
Average Volume 62,155
200-Day Moving Average 21.1926
50-Day Moving Average 18.347
20-Day Moving Average 16.9475
10-Day Moving Average 17.654
Average True Range 1.0631
ADX 18.64
+DI 26.6135
-DI 13.7344
Chandelier Exit (Long, 3 ATRs ) 15.8007
Chandelier Exit (Short, 3 ATRs ) 17.5093
Upper Bollinger Band 18.8329
Lower Bollinger Band 15.0621
Percent B (%b) 0.95
BandWidth 22.249889
MACD Line 0.0051
MACD Signal Line -0.2973
MACD Histogram 0.3024
Fundamentals Value
Market Cap 1.14 Billion
Num Shares 60.8 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -11.45
Price-to-Sales 0.00
Price-to-Book 5.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.35
Resistance 3 (R3) 20.25 19.59 20.07
Resistance 2 (R2) 19.59 19.16 19.64 19.97
Resistance 1 (R1) 19.13 18.89 19.36 19.22 19.88
Pivot Point 18.47 18.47 18.58 18.51 18.47
Support 1 (S1) 18.00 18.04 18.23 18.10 17.44
Support 2 (S2) 17.34 17.77 17.39 17.35
Support 3 (S3) 16.88 17.34 17.25
Support 4 (S4) 16.97